» Articles » PMID: 16868705

25(OH) Vitamin D3 in Patients with Chronic Kidney Disease and Those on Dialysis: Rediscovering Its Importance

Overview
Publisher Springer
Specialty Nephrology
Date 2006 Jul 27
PMID 16868705
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

In terms of both exogenous sources (diet), and endogenous production (activation through exposure to ultraviolet light), vitamin D is unique. Few foods naturally contain vitamin D and only a few are fortified with vitamin D. Most people get more than 90% of their vitamin D requirements from exposure to sunlight. Those who protect their skin from ultraviolet-B radiation with clothing or sunscreen, the elderly, and dark-skinned individuals have limited capacity to produce vitamin D. Vitamin D deficiency is common in the general population and even more common in patients with chronic renal failure (CKD). Increased use of sun-blocking agents and decreased exposure to sunlight, to reduce the risk of skin cancer, attributed to exposure to UV radiation, may contribute to the increase in vitamin D deficiency in the population. These issues are particularly important in the dialysis population who are at particular risk because these, mostly elderly, individuals have an inactive life style and have reduced exposure to sunshine and UV light, thus limiting the actinic synthesis of vitamin D. The nephrology community seems to have overlooked the importance of vitamin D for overall health and well being in patients with CKD. Recently however, several authors have called attention to the role of plasma 25(OH)D3 levels in mineral metabolism dysregulation in patients with chronic kidney diseases, and those on dialysis. Vitamin D not only contributes to skeletal health but also plays a major role in the health of a wide variety of other organ systems. It seems that vitamin D supplementation is the most effective way of preventing vitamin D deficiency.

Citing Articles

The role of vitamin D deficiency in the development of paediatric diseases.

Liu Z, Huang S, Yuan X, Wang Y, Liu Y, Zhou J Ann Med. 2022; 55(1):127-135.

PMID: 36495273 PMC: 9744225. DOI: 10.1080/07853890.2022.2154381.


Ayurvedic Medications as Accelerating Cause of Atraumatic Bilateral Femur Neck Fracture in a Young Indian Male with Kidney Disease: A Unique Case Report.

Ramanath S, Hemant Shah R, Pradyumna Y J Orthop Case Rep. 2019; 9(1):45-48.

PMID: 31245318 PMC: 6588146. DOI: 10.13107/jocr.2250-0685.1302.


Vitamin D-Binding Protein Clearance Ratio Is Significantly Associated with Glycemic Status and Diabetes Complications in a Predominantly Vitamin D-Deficient Population.

Abdella N, Mojiminiyi O J Diabetes Res. 2018; 2018:6239158.

PMID: 29888290 PMC: 5985098. DOI: 10.1155/2018/6239158.


The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients' with low vitamin D.

Mustafar R, Mohd R, Miswan N, Bain A, Cader R, Gafor A Cent Eur J Immunol. 2015; 39(2):236-42.

PMID: 26155130 PMC: 4440033. DOI: 10.5114/ceji.2014.43729.


Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease.

Kalousova M, Dusilova-Sulkova S, Zakiyanov O, Kostirova M, Safranek R, Tesar V Biomed Res Int. 2015; 2015:492365.

PMID: 26064917 PMC: 4434169. DOI: 10.1155/2015/492365.


References
1.
Garland F, Garland C, Gorham E, Young J . Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990; 19(6):614-22. DOI: 10.1016/0091-7435(90)90058-r. View

2.
Nesby-ODell S, Scanlon K, Cogswell M, Gillespie C, Hollis B, Looker A . Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002; 76(1):187-92. DOI: 10.1093/ajcn/76.1.187. View

3.
Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y . 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982; 204(3):713-9. PMC: 1158411. DOI: 10.1042/bj2040713. View

4.
Birge S, Haddad J . 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest. 1975; 56(5):1100-7. PMC: 301971. DOI: 10.1172/JCI108184. View

5.
Ritz E, Boland R, Kreusser W . Effects of vitamin D and parathyroid hormone on muscle: potential role in uremic myopathy. Am J Clin Nutr. 1980; 33(7):1522-9. DOI: 10.1093/ajcn/33.7.1522. View